Company
Overview
Corporate Management
Board of Directors
Corporate and Social Responsibility
Technology
Overview
Publications
Pipeline
Overview
EX937
EX597
Partnerships
News
Investors
Contact
Category:
News
Exxel Pharma Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
Exxel Pharma’s Innovative Small Molecule, EX937, Rapidly Advancing Toward First-In-Human Study for the Treatment of Refractory Chronic Cough
Exxel Pharma to Participate in a “New to Virtual Investor” Segment
Exxel’s CSO Daniele Piomelli receives Entrepreneurial Leader of the Year award from UC Irvine (UCI) Beall Applied Innovation
